• Better patient access to quality care for a population that often receives too little primary care
• High adherence to drug treatment plans at rates
• Lower hospitalization and readmission rates
• Improved clinical outcomes such as LDL levels for patients on drug treatment and HgbA1C levels for diabetics
• High patient satisfaction as measured by net promoter scores which are at an industry leading low 90s.
• High word-of-mouth patient referrals which creates ongoing growth of patients

These results have received national attention. ChenMed has been invited to speak at the White House Physician Forum on Health Reform in 2009 as well as the CMS Innovation Summit in 2012. We continue to look for opportunities to collaborate with other innovators and national health care leaders.